Compounds > dioscin
Page last updated: 2024-09-03

dioscin and Cancer of Colon

dioscin has been researched along with Cancer of Colon in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chai, H; Cordell, GA; Farnsworth, NR; Hollingshead, MG; Kardono, LB; Kinghorn, AD; Lantvit, D; Lee, IS; Mayo, JG; Mi, Q; Ngassapa, O; Peraza-Sánchez, S; Pezzuto, JM; Reyes-Lim, E; Riswan, S; Zhao, W1
Guo, J; Huang, Y; Li, R; Lv, F; Qin, J; Wang, Z; Zhu, H1
Cheng, B; Cui, Y; Hou, L; Huang, L; Li, S; Shen, X; Xu, D1
Chen, H; Han, X; Liu, K; Peng, J; Qi, Y; Xu, L; Xu, Y; Yin, L; Zhao, Y1
Hu, X; Jiang, L; Qing, Y; Tong, Q; Wu, X; Wu, Y1

Other Studies

5 other study(ies) available for dioscin and Cancer of Colon

ArticleYear
Evaluation of the potential cancer chemotherapeutic efficacy of natural product isolates employing in vivo hollow fiber tests.
    Journal of natural products, 2002, Volume: 65, Issue:6

    Topics: Animals; Biological Factors; Colonic Neoplasms; Diosgenin; Disease Models, Animal; Diterpenes; Drug Screening Assays, Antitumor; Female; Heterocyclic Compounds, 3-Ring; HL-60 Cells; Humans; Inhibitory Concentration 50; KB Cells; Leukemia P388; Male; Melanoma; Mice; Molecular Structure; Naphthoquinones; Ovarian Neoplasms; Paclitaxel; Polymers; Prostatic Neoplasms; Triterpenes; Tumor Cells, Cultured

2002
Dioscin reduced chemoresistance for colon cancer and analysis of sensitizing targets.
    Biochemical and biophysical research communications, 2023, 01-01, Volume: 638

    Topics: Apoptosis; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Neoplasm; Fluorouracil; Humans; Oxaliplatin

2023
Dioscin inhibits colon cancer cells' growth by reactive oxygen species-mediated mitochondrial dysfunction and p38 and JNK pathways.
    Anti-cancer drugs, 2018, Volume: 29, Issue:3

    Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Colonic Neoplasms; Diosgenin; HT29 Cells; Humans; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitochondria; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species

2018
iTRAQ-based proteomic analysis of dioscin on human HCT-116 colon cancer cells.
    Proteomics, 2014, Volume: 14, Issue:1

    Topics: Apoptosis; Cell Cycle; Cell Shape; Cell Survival; Colonic Neoplasms; Diosgenin; DNA Damage; HCT116 Cells; Humans; Isotope Labeling; Nitric Oxide; Nitric Oxide Synthase Type II; Proteins; Proteome; Proteomics; Reactive Oxygen Species

2014
Dioscin inhibits colon tumor growth and tumor angiogenesis through regulating VEGFR2 and AKT/MAPK signaling pathways.
    Toxicology and applied pharmacology, 2014, Dec-01, Volume: 281, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Diosgenin; Dose-Response Relationship, Drug; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Male; MAP Kinase Signaling System; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Proto-Oncogene Proteins c-akt; Time Factors; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2

2014